Natrilix Retard (Indapamide)

Indapamide, the active ingredient in Natrilix Retard, is a thiazide‑like diuretic presented as an oral tablet for oral use. It treats hypertension and edema associated with heart failure or renal disease in adults.

GNH USA supplies Natrilix Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal tubular system to manage conditions related to fluid overload and high blood pressure.

Hypertension: reduces systolic and diastolic blood pressure by promoting diuresis and vasodilation. Edema associated with heart failure: increases urinary output to relieve fluid accumulation and lower cardiac preload. Edema associated with renal disease: facilitates removal of excess fluid while helping control blood pressure.

Common Side Effects: - Electrolyte imbalance (e.g., low potassium) - Dizziness or light‑headedness - Headache - Increased frequency of urination - Fatigue - Nausea

Serious or Rare Side Effects: - Severe dehydration - Significant electrolyte disturbances (hypokalemia, hyponatremia) - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., agranulocytosis) - Acute renal impairment - Pancreatitis

Before initiating therapy, consider the following precautions: - Monitor electrolytes: regular blood tests to detect imbalances. - Assess renal function: adjust use in patients with impaired kidneys. - Use cautiously in gout: may increase uric acid levels. - Avoid in severe hepatic impairment: limited metabolism data. - Adjust diabetes medications: diuretic effect may enhance hypoglycaemia. - Store at room temperature: keep in the original pack, protect from moisture.

Indapamide may interact with several medicines; awareness of major and moderate interactions helps ensure safety.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity. - NSAIDs: may blunt diuretic efficacy and affect kidney function. - ACE inhibitors or ARBs: heightened risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure lowering effect. - Digoxin: possible increase in serum digoxin levels. - Warfarin: potential alteration of INR values.